Today is July 01, 2024. All times in Eastern Daylight Time.
Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
06/02/2024 - 08:30 AM
BUSINESS WIRE
IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
06/02/2024 - 08:05 AM
BUSINESS WIRE
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
06/02/2024 - 08:00 AM
BUSINESS WIRE
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
06/02/2024 - 08:00 AM
BUSINESS WIRE
ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
06/02/2024 - 08:00 AM
BUSINESS WIRE
Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
06/02/2024 - 08:00 AM
BUSINESS WIRE
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapy
06/02/2024 - 08:00 AM
BUSINESS WIRE
Accutar Biotechnology在2024年ASCO年會上公布了在ER陽性/HER2陰性乳癌病患中展開AC699單一療法第一期試驗的資料
06/02/2024 - 07:40 AM
BUSINESS WIRE
June Joy at Juicy Stakes Casino
06/02/2024 - 07:00 AM
BUSINESS WIRE
Bihar collabora con Bidgely per ridurre i furti di energia e le perdite di ricavi tramite l'analisi dei dati alimentata dall'IA
06/01/2024 - 03:42 PM
BUSINESS WIRE
1
...
1347
1348
1349
1350
1351
1352
1353
1354
1355
1356
1357
« Previous
Next »